Sang Mo Kang, MD

Cornell University, Ithaca, NY, B.A., 1986, Chemistry
Harvard Medical School, Boston, MA, MD, 1992, Magna Cum Laude
General Surgery Program, University of California at San Francisco, June 1992 to June 1999
University of California, San Francisco, CA, 7/99-3/01, Fellow in Transplant Surgery

• 6/84 - 6/86
  Research Assistant in Department of Chemistry, Cornell University, Ithaca NY.
• 1986, 1987
  Summer Research Fellow, National Institutes of Health, Bethesda, MD.
• 7/89 - 8/91
  Howard Hughes Medical Institute - NIH Research Fellow in Laboratory of Immunology, National Institutes of Health, Bethesda, MD.
• 6/95 - 6/97
  Howard Hughes Medical Institute Physician Postdoctoral Fellow in Transplantation Laboratory and Hormone Research Institute, University of California, San Francisco, CA.
• 6/92 - 3/01
  General Surgery Resident and Transplant Fellow, University of California, San Francisco, CA.
• 4/01 - 7/08
  Assistant Professor of Surgery, University of California, San Francisco, CA.
• 7/08 - present
  Associate Professor of Surgery, University of California, San Francisco, CA.

• 1986
  Phi Beta Kappa
• 1986
  Merck Scholarship
• 1985-87
  Beinecke Memorial National Scholar
• 1987
  NIH Outstanding Summer Research Fellow Award
• 1989
  Francis D. Moore Scholarship
• 1991-92
  Howard Hughes Medical Institute Continuing Fellowship for "exceptional promise in biomedical research"
• 1992
  Henry Asbury Christian Award for outstanding academic achievement
• 1995
  British Journal of Surgery Award for outstanding surgical resident
• 1995-97
  Howard Hughes Medical Institute Postdoctoral Fellowship Award
• 1997
  ASTS Upjohn Award for most outstanding paper
• 1997-98
  Hefne Research Grant
• 1998
  Elected to AOA for excellence in teaching
• 1999
  ASTS Travel Award
• 1999-2001
  ASTS Novartis Fellowship in Transplantation
• 2003-2005
  ASTS Faculty Development Award

• Kang SM; Grilli M; Lenardo MJ. NF-kappa C down-regulation during activation of CD4+ lymphocytes. Modern Trends in Leukemia X, 1991, 256-62.
• Brorson KA; Beverly B; Kang SM; Lenardo MJ; Schwartz RH. Transcriptional regulation of cytokine genes in nontransformed T cells. Journal of Immunology, 1991 Nov 15, 147(10): 3601-9.
• Beverly B; Kang SM; Lenardo MJ; Schwartz RH. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. International Immunology, 1992 Jun, 4(6): 661-71.
• Kang SM; Tran AC; Grilli M; Lenardo MJ. NF-kappa B subunit regulation in nontransformed CD4+ lymphocytes. Science, 1992 Jun 5, 256(5062): 1452-6.
• Kang, SM; Tsang W; Doll S; Scherle P; Ko HS; Tran AC; Lenardo MJ; Staudt LM. Induction of the POU domain transcription factor Oct-2 during T-cell activation by cognate antigen. Molecular and Cellular Biology, 1992 Jul, 12(7): 3149-54.
• Kang, SM; Beverly B; Tran AC; Brorson K; Schwartz RH; Lenardo MJ. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science, 1992 Aug 21, 257: 1134-8.
• Kuang AA; Novak KD; Kang SM; Bruhn K; Lenardo MJ. Interaction between NF-kappa B and serum response factor binding elements activates an IL-2 receptor alpha-chain enhancer specifically in T lymphocytes. Molecular and Cellular Biology, 1993 Apr; 13(4): 2536-45.
• Umlauf SW; Beverly B; Kang SM; Brorson K; Tran AC; Schwartz RH. Molecular regulation of the IL-2 gene: rheostatic control of the immune system. Immunology Reviews, 1993 June; 35: 177-97.
• Aanstoot, H. J., Kang SM., Kim, J., Lindsay, L. A., Roll, U., Knip, M., Atkinson, M., Mose-Larsen, P., Fey, S., Ludvigsson, J., Landin, M., Bruining, J., Maclaren, N., Akerblom, H. K., and Baekkeskov, S. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. Journal of Clinical Investigation 1996, 97: 2772-83.
• Kang SM; Schneider DB; Lin Z; Hanahan D; Dichek DA; Stock PG; Baekkeskov S. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Medicine, 1997 Jul, 3(7):738-43.
• Kang SM; Hoffmann A; Le D; Springer ML; Stock PG; Blau HM. Immune response and myoblasts that express Fas ligand. Science, 1997 Nov 14, 278(5341):1322-4.
• Kang SM; Lin Z; Ascher NL; Stock PG. Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection. Transplantation Proceedings, 1998 Mar, 30(2):538.
• O'Rourke RW, Kang SM, Lower, JA, Feng S, Ascher NL, Baekkeskov S, Stock PG. A dendritic cell line genetically modified to express CTLA4-Ig as a means to prolong islet allograft survival. . Transplantation. 2000 Apr 15;69(7):1440-6.
• Kang SM; Braat D; Schneider DB; O'Rourke R; Lin Z; Ascher NL; Dichek DA; Baekkeskov S; and Stock PG. A non-cleavable mutant of Fas Ligand does not prevent neutrophilic destruction of islet transplants. Transplantation. 2000 May 15;69(9):1813-7.
• Meng MV, Kang SM, Duh QY, Stoller MI, Freise CE. Laparoscopic live donor nephrectomy at the University of California at San Francisco. Clinical Transplantation. 2001; 113-21.
• Freise CE, Kang SM, Feng S, Hirose R, Stock P. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. Arch Surg. 2003 Oct;138(10):1121-5; discussion 1125-6.
• Abrahams HM, Freise CE, Kang SM, Stoller ML, Meng MV. Technique, indications and outcomes of pure laparoscopic right donor nephrectomy. J Urol. 2004 May;171(5):1793-6.
• Visser B, Suh I, Way LW, Kang SM. Congenital Choledochal Cysts in Adults. Archives of Surgery. Archives of Surgery, 2004; 139:855-862.